Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

17.00
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
16.97
Today|||52-Week Range
22.35
-12.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$84.3B

Company Description

'GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.

Contact Information

GlaxoSmithKline Plc
980 Great West Road
Brentford Greater London TW8 9GS
P:442080475000
Investor Relations:
442080475543

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Emma WalmsleyChief Executive Officer & Executive Director
Simon DingemansChief Financial Officer & Executive Director
Patrick J. T. VallanceExecutive Director, President-R&D
Karenann K. TerrellChief Technology Officer
Nick HironsSenior VP-Global Ethics & Compliance Officer